Assessment of H. pylori seropositivity in Multiple sclerosis and its relationship with disease severity in Egypt
El-Samahy, M., Anani, M., Attia, F., Abdulrehim, M., Abdul, Y., Gaber, A., Salama, B., Hashem, A., Abd-Elahady, M., Fouad, M., Elwy, N. (2024). Assessment of H. pylori seropositivity in Multiple sclerosis and its relationship with disease severity in Egypt. EKB Journal Management System, 33(3), 103-109. doi: 10.21608/ejmm.2024.298029.1266
Mohamed El-Samahy; Maha M. Anani; Fadia Attia; Marwa M. Abdulrehim; Yasser R. Abdul; Ahmed Gaber; Bassam M. Salama; Asmaa A. Hashem; Mohamed E. Abd-Elahady; Mohamed A. Fouad; Naglaa Elwy. "Assessment of H. pylori seropositivity in Multiple sclerosis and its relationship with disease severity in Egypt". EKB Journal Management System, 33, 3, 2024, 103-109. doi: 10.21608/ejmm.2024.298029.1266
El-Samahy, M., Anani, M., Attia, F., Abdulrehim, M., Abdul, Y., Gaber, A., Salama, B., Hashem, A., Abd-Elahady, M., Fouad, M., Elwy, N. (2024). 'Assessment of H. pylori seropositivity in Multiple sclerosis and its relationship with disease severity in Egypt', EKB Journal Management System, 33(3), pp. 103-109. doi: 10.21608/ejmm.2024.298029.1266
El-Samahy, M., Anani, M., Attia, F., Abdulrehim, M., Abdul, Y., Gaber, A., Salama, B., Hashem, A., Abd-Elahady, M., Fouad, M., Elwy, N. Assessment of H. pylori seropositivity in Multiple sclerosis and its relationship with disease severity in Egypt. EKB Journal Management System, 2024; 33(3): 103-109. doi: 10.21608/ejmm.2024.298029.1266

Assessment of H. pylori seropositivity in Multiple sclerosis and its relationship with disease severity in Egypt

Egyptian Journal of Medical Microbiology
Volume 33, Issue 3, July 2024, Page 103-109  XML PDF (312.2 K)
Document Type: New and original researches in the field of Microbiology.
DOI: 10.21608/ejmm.2024.298029.1266
View on SCiNiTO View on SCiNiTO
Authors
Mohamed El-Samahy1; Maha M. Anani email 2; Fadia Attia2; Marwa M. Abdulrehim3; Yasser R. Abdul4; Ahmed Gaber5; Bassam M. Salama5; Asmaa A. Hashem6; Mohamed E. Abd-Elahady1; Mohamed A. Fouad7; Naglaa Elwy2
1Department of Neurology, Faculty of Medicine, Suez Canal University, Ismailia-Egypt
2Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia-Egypt
3Department of Internal Medicine, Faculty of Medicine (For Girls), Al-Azhar University, Cairo, Egypt
4Department of Gastroentrology, Hepatology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Dommita, Egypt
5Department of Endemic and Infectious diseases, Faculty of Medicine, Suez Canal University, Ismailia-Egypt
6Department of Medical Microbiology and Immunology, Faculty of Medicine, Suez Canal University, Ismailia-Egypt
7Department of Microbiology and Immunology Department, Faculty of Medicine, Benha University, Egypt
Abstract
Background: Studies have shown that H.Pylori might have a protective role in Multiple Sclerosis MS. However, there are inadequate and inconsistent epidemiological data regarding H. pylori serology among MS patients in Egypt. Objectives: We aim to measure and analyze the serum level of IgM and IgG of H. pylori among different clinical subsets of MS and to correlate it with the number of relapses, duration of disease, Disease Modifying Therapy DMT and Expanded Disability Status Scale EDSS. Methods: This is a case-control study that included 22 patients with SPMS secondary progressive multiple sclerosis and RRMS relapsing remitting multiple sclerosis and 22 control are recruited. The study comprised patients with a confirmed diagnosis of MS in accordance with the 2017 revisions to McDonald's criteria. Results: H. pylori immunoglobulin M IgM and IgG seropositivity in cases and control groups showed no significant difference among both groups. Conclusion: There was an insignificant association between the H. pylori antibodies and MS. Studies with a larger sample size are required to support our findings even more.
Keywords
H. pylori; Multiple Sclerosis; antibodies
Statistics
Article View: 229
PDF Download: 103